ABDULLAHI IBRAHIM UBA

Global Burden of Disease (GBD)

Bilimsel Kuruluş

European Cooperation in Science and Technology (COST): COST Action CA20121, Bench to bedside transition for pharmacological regulation of NRF2 in noncommunicable diseases

Bilimsel Kuruluş

International Natural Product Science Task Force

Bilimsel Kuruluş

European Cooperation in Science and Technology (COST) Action CM1406: Epigenetic Chemical Biology

Bilimsel Kuruluş

Adverse drug reaction profiles of histone deacetylase inhibitors

Yayın Kurulu Üyeliği

Introduction of new quinolone-2-thio-acetamide-propane hydrazide-benzimidazole derivatives as new α-glucosidase and α-amylase inhibitors

Yayın Kurulu Üyeliği

Network pharmacology and metabolomics reveal mathurameha, a Thai traditional Anti-Diabetic formula, enhances glucose metabolism through PI3K-AKT/AMPK/GLUT4 pathway modulation

Yayın Kurulu Üyeliği

Identification of potential VP40 inhibitor of Marburg virus through molecular docking, pharmacokinetic analysis and molecular dynamics simulation

Yayın Kurulu Üyeliği

Treatment of non-small cell lung cancer using chem-bioinformatics-driven engineering of exosomal cargo-vehicle for telmisartan and pioglitazone targeted-delivery

Yayın Kurulu Üyeliği

Contribution of reversible histone acetylation to freeze tolerance and recovery in wood frog kidneys

Yayın Kurulu Üyeliği

Development of mercapto-phenyl-1,2,4-triazole bearing thio-quinoline as a novel class of tyrosinase inhibitors: an in vitro and in silico study

Yayın Kurulu Üyeliği

Synthesis, in vitro evaluation and computational modelling of benzene sulfonamide derivatives as Dickkopf 1 inhibitors for anticancer drug development

Yayın Kurulu Üyeliği

Theoretical studies of arbutin, glutathione, and sea cucumber extracts as inhibitors of tyrosinase

Yayın Kurulu Üyeliği

MEN: leveraging explainable multimodal encoding network for precision prediction of CYP450 inhibitors

Yayın Kurulu Üyeliği

Characterization of tricyclic anti-depressant drugs efficacy via topological indices

Yayın Kurulu Üyeliği

Integrative machine learning and molecular simulation approaches identify GSK3β inhibitors for neurodegenerative disease therapy

Yayın Kurulu Üyeliği

Plasma-activated water modulates taxanes production and phenylalanineammonia-lyase activity in Taxus baccata cell culture

Yayın Kurulu Üyeliği

Drug delivery process simulation—Quantifying the conformation dynamics of paclitaxel and cremophor EL

Yayın Kurulu Üyeliği

Enhanced urease inhibitory activity of quercetin via conjugation with silver nanoparticles: synthesis, characterization, and DFT study

Yayın Kurulu Üyeliği

Design, synthesis and biological evaluation of novel kojic acid triazole hybrids as tyrosinase inhibitors and antibrowning agents

Yayın Kurulu Üyeliği

Comprehensive computational strategies for multi-target drug discovery in inflammatory bowel disease utilizing bioactive compounds

Yayın Kurulu Üyeliği

Electrochemical, quantum chemical, and thermodynamic investigation of a Schiff base corrosion inhibitor for XC70 steel

Yayın Kurulu Üyeliği

Computational exploration of Eucommia ulmoides flavonoids as potential RANKL inhibitors via molecular docking and dynamics simulations

Yayın Kurulu Üyeliği

New benzimidazole-triazole glycoconjugates as anti-cancer agents and EGFR inhibitors

Yayın Kurulu Üyeliği

Editorial: Use of computational tools for designing epigenetic drugs

Konuk Editör

CHARMM-GUI Training School

Kurs

CHARMM-GUI Training School: Application of MD simulations in Biosciences

External Examiner for Ph.D. Biomolecular and Pharmaceutical

Thesis title: “Design, synthesis, and biological evaluation of novel opioid peptide ligands” (by Dr. Alice Della Valle); “Pharmacological eg5 inhibition and its implication on mitotic and non-mitotic functions in different in vitro tumoral models” (by Dr. Alessia Ricci); “From Academy to Industry: development of GMP grade perinatal tissue procedures and setting up of a Multifunctional Prototype Isolator” (by Dr. Manuela Santalucia).